Oral chemotherapeutic agents in metastatic hormone-sensitive prostate cancer: A network meta-analysis of randomized controlled trials

Oral chemotherapeutic agents in metastatic hormone-sensitive prostate cancer: A network meta-analysis of randomized controlled trials

Background: Multiple oral chemotherapeutic agents for metastatic hormone-sensitive prostate cancer (mHSPC) have been developed for conjugated use with conventional androgen deprivation therapy (ADT). Several randomized controlled trials (RCTs) report significant benefits in mHSPC patients. Therefore...

Full description

Bibliographic Details
Main Authors: Yong Seong Lee, Seong Hwan Kim, Jong Hyun Tae, In Ho Chang, Tae-Hyoung Kim, Soon Chul Myung, Myoungsuk Kim, Tuan Thanh Nguyen, Joongwon Choi, Jung Hoon Kim, Jin Wook Kim, Se Young Choi
Format: Article
Language:English
Published: Elsevier 2023-09-01
Series:Prostate International
Subjects:
Castration-sensitive
Combination therapy
Network meta-analysis
Systematic review
Triplet therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2287888223000338

Internet

http://www.sciencedirect.com/science/article/pii/S2287888223000338

Similar Items